Volume 20, Issue 43 2402715
Review

Delivery of mRNA Using Biomimetic Vectors: Progress and Challenges

Menghao Yin

Menghao Yin

School of Pharmaceutical Sciences, Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou, 450001 China

Search for more papers by this author
Hanruo Sun

Hanruo Sun

School of Pharmaceutical Sciences, Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou, 450001 China

Search for more papers by this author
Yanan Li

Yanan Li

School of Pharmaceutical Sciences, Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou, 450001 China

Search for more papers by this author
Jingge Zhang

Jingge Zhang

School of Pharmaceutical Sciences, Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou, 450001 China

Search for more papers by this author
Jinjin Wang

Jinjin Wang

School of Pharmaceutical Sciences, Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou, 450001 China

Search for more papers by this author
Yan Liang

Corresponding Author

Yan Liang

School of Pharmaceutical Sciences, Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou, 450001 China

E-mail: [email protected]; [email protected]

Search for more papers by this author
Kaixiang Zhang

Corresponding Author

Kaixiang Zhang

School of Pharmaceutical Sciences, Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou, 450001 China

E-mail: [email protected]; [email protected]

Search for more papers by this author
First published: 14 July 2024
Citations: 6

Abstract

Messenger RNA (mRNA) is an emerging class of therapeutic agents for treating a wide range of diseases. However, due to the instability and low cell transfection rate of naked mRNA, the expression of delivered mRNA in target cells or tissues in vivo requires delivery strategies. Biomimetic vectors hold advantages such as high biocompatibility, tissue specific targeting ability and efficient delivery mechanisms, potentially overcoming challenges faced by other delivery vectors. In this review, biomimetic vector-based mRNA delivery systems are summarized and discuss the possible challenges and prospects of such delivery systems, which may contribute to the progress and application of mRNA-based therapy in the biomedical field.

Conflict of Interest

The authors declare no conflict of interest.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.